Publication Results

Generate Report

Add publications by marking their checkboxes, or

Deciding on breast cancer risk reduction: The role of counseling in individual decision-making - A qualitative study.

Blakeslee SB,  McCaskill-Stevens W,  Parker PA,  Gunn CM,  Bandos H,  Bevers TB,  Battaglia TA,  Fagerlin A,  Müller-Nordhorn J,  Holmberg C
Patient Educ Couns 2017 Dec;100(12):2346-2354
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 28734560
PMC ID: PMC5683919

NRG Oncology/National Surgical Adjuvant Breast and Bowel Project Decision-Making Project-1 Results: Decision Making in Breast Cancer Risk Reduction.

Holmberg C,  Bandos H,  Fagerlin A,  Bevers TB,  Battaglia TA,  Wickerham DL,  McCaskill-Stevens WJ
Cancer Prev Res (Phila) 2017 Nov;10(11):625-634
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 28978566
PMC ID: PMC5848501

Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

Polite BN,  Adams-Campbell LL,  Brawley OW,  Bickell N,  Carethers JM,  Flowers CR,  Foti M,  Gomez SL,  Griggs JJ,  Lathan CS,  Li CI,  Lichtenfeld JL,  McCaskill-Stevens W,  Paskett ED
J Clin Oncol 2017 Sep 10;35(26):3075-3082
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 28737975
PMC ID: not available

Charting the Future of Cancer Health Disparities Research: A Position Statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

Polite BN,  Adams-Campbell LL,  Brawley OW,  Bickell N,  Carethers JM,  Flowers CR,  Foti M,  Gomez SL,  Griggs JJ,  Lathan CS,  Li CI,  Lichtenfeld JL,  McCaskill-Stevens W,  Paskett ED
Cancer Res 2017 Sep 1;77(17):4548-4555
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 28739629
PMC ID: not available

Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

Polite BN,  Adams-Campbell LL,  Brawley OW,  Bickell N,  Carethers JM,  Flowers CR,  Foti M,  Gomez SL,  Griggs JJ,  Lathan CS,  Li CI,  Lichtenfeld JL,  McCaskill-Stevens W,  Paskett ED
CA Cancer J Clin 2017 Sep;67(5):353-361
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 28738442
PMC ID: not available

Identifying and Creating the Next Generation of Community-Based Cancer Prevention Studies: Summary of a National Cancer Institute Think Tank.

McCaskill-Stevens W,  Pearson DC,  Kramer BS,  Ford LG,  Lippman SM
Cancer Prev Res (Phila) 2017 Feb;10(2):99-107
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director
PubMed ID: 27965286
PMC ID: PMC5292088

Results from NRG oncology/NSABP protocol DMP-1: Women's decision-making in breast cancer risk reduction

Holmberg C,  Bandos H,  Fagerlin A,  Bevers T B,  Battaglia T A,  Wickerham D L,  McCaskill-Stevens W
Cancer Res 2016 Feb 15;76(Suppl 4)
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: not available
PMC ID: not available

Clinical Trial Assessment of Infrastructure Matrix Tool to Improve the Quality of Research Conduct in the Community.

Dimond EP,  Zon RT,  Weiner BJ,  St Germain D,  Denicoff AM,  Dempsey K,  Carrigan AC,  Teal RW,  Good MJ,  McCaskill-Stevens W,  Grubbs SS,  Dimond EP,  Zon RT,  Weiner BJ,  St Germain D,  Denicoff AM,  Dempsey K,  Carrigan AC,  Teal RW,  Good MJ,  McCaskill-Stevens W,  Grubbs SS
J Oncol Pract 2016 Jan;12(1):63-35
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 26627979
PMC ID: PMC4976452

A Report of the Women's Health Congress Workshop on The Health of Women of Color: A Critical Intersection at the Corner of Sex/Gender and Race/Ethnicity.

Plank-Bazinet JL,  Kornstein SG,  Clayton JA,  McCaskill-Stevens W,  Wood L,  Cook N,  Tajuddin SM,  Brown GM,  Harris T,  Evans MK,  Begg L,  Brooks CE,  Miller LR,  Mistretta AC,  Cornelison TL
J Womens Health (Larchmt) 2016 Jan;25(1):4-10
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 26771559
PMC ID: PMC4741201

Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology Statement.

Ligibel JA,  Alfano CM,  Hershman D,  Ballard RM,  Bruinooge SS,  Courneya KS,  Daniels EC,  Demark-Wahnefried W,  Frank ES,  Goodwin PJ,  Irwin ML,  Levit LA,  McCaskill-Stevens W,  Minasian LM,  O'Rourke MA,  Pierce JP,  Stein KD,  Thomson CA,  Hudis CA
J Clin Oncol 2015 Nov 20;33(33):3961-7
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director
PubMed ID: 26324364
PMC ID: not available

Increasing Minority Enrollment Onto Clinical Trials: Practical Strategies and Challenges Emerge From the NRG Oncology Accrual Workshop.

Brooks SE,  Muller CY,  Robinson W,  Walker EM,  Yeager K,  Cook ED,  Friedman S,  Somkin CP,  Brown CL,  McCaskill-Stevens W
J Oncol Pract 2015 Nov;11(6):486-90
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 26464496
PMC ID: PMC5706134

My Lived Experiences Are More Important Than Your Probabilities: The Role of Individualized Risk Estimates for Decision Making about Participation in the Study of Tamoxifen and Raloxifene (STAR).

Holmberg C,  Waters EA,  Whitehouse K,  Daly M,  McCaskill-Stevens W
Med Decis Making 2015 Nov;35(8):1010-22
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 26183166
PMC ID: PMC4592416

Gaining control over breast cancer risk: Transforming vulnerability, uncertainty, and the future through clinical trial participation - a qualitative study.

Holmberg C,  Whitehouse K,  Daly M,  McCaskill-Stevens W
Sociol Health Illn 2015 Nov;37(8):1373-87
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 26235092
PMC ID: PMC4609249

Cooperative Group Trials in the Community Setting.

Lloyd Wade J 3rd,  Petrelli NJ,  McCaskill-Stevens W
Semin Oncol 2015 Oct;42(5):686-92
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 26433550
PMC ID: PMC4692715

Casing uncertainty in LCIS recommendations through two patient narratives

Blakeslee Sarah B.,  Parker Patricia A.,  Gunn Christine M.,  Bandos Hanna,  Battaglia Tracy A.,  Bevers Therese B.,  McCaskill-Stevens Worta,  Mueller-Nordhorn Jacqueline,  Holmberg Christine
Eur J Cancer Care 2015 Sep 1;24(Suppl 2):32-32
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: not available
PMC ID: not available

Cancer Care Delivery Research: Building the Evidence Base to Support Practice Change in Community Oncology.

Kent EE,  Mitchell SA,  Castro KM,  DeWalt DA,  Kaluzny AD,  Hautala JA,  Grad O,  Ballard RM,  McCaskill-Stevens WJ,  Kramer BS,  Clauser SB
J Clin Oncol 2015 Aug 20;33(24):2705-11
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director
PubMed ID: 26195715
PMC ID: PMC4559611

Creating a "culture of research" in a community hospital: Strategies and tools from the National Cancer Institute Community Cancer Centers Program.

Dimond EP,  St Germain D,  Nacpil LM,  Zaren HA,  Swanson SM,  Minnick C,  Carrigan A,  Denicoff AM,  Igo KE,  Acoba JD,  Gonzalez MM,  McCaskill-Stevens W
Clin Trials 2015 Jun;12(3):246-56
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 25691600
PMC ID: PMC4420772

Decision-making in breast cancer risk reduction: Results from a nested qualitative study from NRG Oncology/NSABP protocol DMP-1

Blakeslee Sarah B.,  Parker Patricia A.,  Gunn Christine M.,  Bandos Hanna,  Bevers Therese Bartholomew,  Battaglia Tracy Ann,  Fagerlin Angela,  McCaskill-Stevens Worta J.,  Holmberg Christine
J Clin Oncol 2015 May 20;33(15):Abstract e17569
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: not available
PMC ID: not available

Creating a national collaborative strategy to enhance trial accrual in NCI's National Clinical Trials Network (NCTN) in the era of precision medicine

Denicoff Andrea,  Massett Holly A.,  Mishkin Grace E.,  Bangs Rick,  Berlin Jordan,  Bischoff Miriam B.,  DeSanto Frank,  Duli Anne,  Horvath Laura E.,  Katz Michael S.,  Lambersky Ruth,  Mann Bhupinder Singh,  McCaskill-Stevens Worta J.,  Seibel Nita,  Stine Sharon Hartson,  Williams Wade,  Mooney Margaret M.,  Abrams Jeffrey S.
J Clin Oncol 2015 May 20;33(15):Abstract 6589
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: not available
PMC ID: not available

Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers Program.

Langford AT,  Resnicow K,  Dimond EP,  Denicoff AM,  Germain DS,  McCaskill-Stevens W,  Enos RA,  Carrigan A,  Wilkinson K,  Go RS
Cancer 2014 Mar 15;120(6):877-84
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 24327389
PMC ID: PMC3947654

Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual.

St Germain D,  Denicoff AM,  Dimond EP,  Carrigan A,  Enos RA,  Gonzalez MM,  Wilkinson K,  Mathiason MA,  Duggan B,  Einolf S,  McCaskill-Stevens W,  Bryant DM,  Thompson MA,  Grubbs SS,  Go RS
J Oncol Pract 2014 Mar;10(2):e73-80
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 24424313
PMC ID: PMC3948711

Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597.

Karp DD,  Lee SJ,  Keller SM,  Wright GS,  Aisner S,  Belinsky SA,  Johnson DH,  Johnston MR,  Goodman G,  Clamon G,  Okawara G,  Marks R,  Frechette E,  McCaskill-Stevens W,  Lippman SM,  Ruckdeschel J,  Khuri FR
J Clin Oncol 2013 Nov 20;31(33):4179-87
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 24002495
PMC ID: PMC3821010

The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.

Denicoff AM,  McCaskill-Stevens W,  Grubbs SS,  Bruinooge SS,  Comis RL,  Devine P,  Dilts DM,  Duff ME,  Ford JG,  Joffe S,  Schapira L,  Weinfurt KP,  Michaels M,  Raghavan D,  Richmond ES,  Zon R,  Albrecht TL,  Bookman MA,  Dowlati A,  Enos RA,  Fouad MN,  Good M,  Hicks WJ,  Loehrer PJ Sr,  Lyss AP,  Wolff SN,  Wujcik DM,  Meropol NJ
J Oncol Pract 2013 Nov;9(6):267-76
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 24130252
PMC ID: PMC3825288

Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43.

Siziopikou KP,  Anderson SJ,  Cobleigh MA,  Julian TB,  Arthur DW,  Zheng P,  Mamounas EP,  Pajon ER,  Behrens RJ,  Eakle JF,  Leasure NC,  Atkins JN,  Polikoff JA,  Seay TE,  McCaskill-Stevens WJ,  Rabinovitch R,  Costantino JP,  Wolmark N
Breast Cancer Res Treat 2013 Nov;142(2):415-21
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 24202240
PMC ID: PMC4962781

National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene trial: advancing the science of recruitment and breast cancer risk assessment in minority communities.

McCaskill-Stevens W,  Wilson JW,  Cook ED,  Edwards CL,  Gibson RV,  McElwain DL,  Figueroa-Moseley CD,  Paskett ED,  Roberson NL,  Wickerham DL,  Wolmark N
Clin Trials 2013 Apr;10(2):280-91
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 23335675
PMC ID: PMC4059676
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

The NCI Community Oncology Research Program: what every clinician needs to know.

McCaskill-Stevens W,  Lyss AP,  Good M,  Marsland T,  Lilenbaum R
Am Soc Clin Oncol Educ Book 2013
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 23714464
PMC ID: not available

Chemoprevention for breast cancer.

Bozovic-Spasojevic I,  Azambuja E,  McCaskill-Stevens W,  Dinh P,  Cardoso F
Cancer Treat Rev 2012 Aug;38(5):329-39
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 21856081
PMC ID: not available

Race and the prognostic influence of p53 in women with breast cancer.

Dookeran KA,  Dignam JJ,  Holloway N,  Ferrer K,  Sekosan M,  McCaskill-Stevens W,  Gehlert S
Ann Surg Oncol 2012 Jul;19(7):2334-44
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 22434242
PMC ID: PMC4281085

Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer.

Fisch MJ,  Lee JW,  Weiss M,  Wagner LI,  Chang VT,  Cella D,  Manola JB,  Minasian LM,  McCaskill-Stevens W,  Mendoza TR,  Cleeland CS
J Clin Oncol 2012 Jun 1;30(16):1980-8
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 22508819
PMC ID: PMC3383175

Challenges in ductal carcinoma in situ risk communication and decision-making: report from an American Cancer Society and National Cancer Institute workshop.

Partridge AH,  Elmore JG,  Saslow D,  McCaskill-Stevens W,  Schnitt SJ
CA Cancer J Clin 2012 May-Jun;62(3):203-10
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 22488610
PMC ID: PMC4112288

A critical review of the enrollment of black patients in cancer clinical trials.

Banda DR,  Germain DS,  McCaskill-Stevens W,  Ford JG,  Swain SM
Am Soc Clin Oncol Educ Book 2012 :153-7
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 24451726
PMC ID: not available

Chemoprevention for breast cancer: overcoming barriers to treatment.

Brewster AM,  Davidson NE,  McCaskill-Stevens W
Am Soc Clin Oncol Educ Book 2012 :85-90
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 24451714
PMC ID: not available

Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer.

Kim C,  Tang G,  Pogue-Geile KL,  Costantino JP,  Baehner FL,  Baker J,  Cronin MT,  Watson D,  Shak S,  Bohn OL,  Fumagalli D,  Taniyama Y,  Lee A,  Reilly ML,  Vogel VG,  McCaskill-Stevens W,  Ford LG,  Geyer CE Jr,  Wickerham DL,  Wolmark N,  Paik S
J Clin Oncol 2011 Nov 1;29(31):4160-7
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program ;  Office of the Director
PubMed ID: 21947828
PMC ID: PMC3208536
Clinical Trials: Breast Cancer Prevention Trial (BCPT)

Comorbidities in the aging breast cancer population: are current assessments leading to improved outcomes?

McCaskill-Stevens W,  Abrams JS
J Natl Cancer Inst 2011 Jul 20;103(14):1072-3
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 21719778
PMC ID: PMC3143423

Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older.

Freedman AN,  Yu B,  Gail MH,  Costantino JP,  Graubard BI,  Vogel VG,  Anderson GL,  McCaskill-Stevens W
J Clin Oncol 2011 Jun 10;29(17):2327-33
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 21537036
PMC ID: PMC3107748
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

SI RLTD: Risk Scores and Decision Making: The Anatomy of a Decision to Reduce Breast Cancer Risk.

Holmberg C,  Daly M,  McCaskill-Stevens W
J Nurs Healthc Chronic Illn 2010 Dec;2(4):271-280
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 21731580
PMC ID: PMC3124706

Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology Program.

Minasian LM,  Carpenter WR,  Weiner BJ,  Anderson DE,  McCaskill-Stevens W,  Nelson S,  Whitman C,  Kelaghan J,  O'Mara AM,  Kaluzny AD
Cancer 2010 Oct 1;116(19):4440-9
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director
PubMed ID: 20572032
PMC ID: PMC2945622

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.

Vogel VG,  Costantino JP,  Wickerham DL,  Cronin WM,  Cecchini RS,  Atkins JN,  Bevers TB,  Fehrenbacher L,  Pajon ER,  Wade JL 3rd,  Robidoux A,  Margolese RG,  James J,  Runowicz CD,  Ganz PA,  Reis SE,  McCaskill-Stevens W,  Ford LG,  Jordan VC,  Wolmark N,  National Surgical Adjuvant Breast and Bowel Project
Cancer Prev Res (Phila) 2010 Jun;3(6):696-706
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program ;  Community Clinical Oncology Program
PubMed ID: 20404000
PMC ID: PMC2935331
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

p53 as a marker of prognosis in African-American women with breast cancer.

Dookeran KA,  Dignam JJ,  Ferrer K,  Sekosan M,  McCaskill-Stevens W,  Gehlert S
Ann Surg Oncol 2010 May;17(5):1398-405
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Community Clinical Oncology Program
PubMed ID: 20049641
PMC ID: not available

Multidisciplinary meeting on male breast cancer: summary and research recommendations.

Korde LA,  Zujewski JA,  Kamin L,  Giordano S,  Domchek S,  Anderson WF,  Bartlett JM,  Gelmon K,  Nahleh Z,  Bergh J,  Cutuli B,  Pruneri G,  McCaskill-Stevens W,  Gralow J,  Hortobagyi G,  Cardoso F
J Clin Oncol 2010 Apr 20;28(12):2114-22
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 20308661
PMC ID: PMC2860409

Impact of supplemental site grants to increase African American accrual for the Selenium and Vitamin E Cancer Prevention Trial.

Cook ED,  Arnold KB,  Hermos JA,  McCaskill-Stevens W,  Moody-Thomas S,  Probstfield JL,  Hamilton SJ,  Campbell RD,  Anderson KB,  Minasian LM
Clin Trials 2010 Feb;7(1):90-9
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Community Clinical Oncology Program ;  Prostate and Urologic Cancer
PubMed ID: 20156960
PMC ID: PMC3956599
Clinical Trials: Selenium and Vitamin E Cancer Prevention Trial (SELECT)

The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial.

de Azambuja E,  McCaskill-Stevens W,  Francis P,  Quinaux E,  Crown JP,  Vicente M,  Giuliani R,  Nordenskjöld B,  Gutiérez J,  Andersson M,  Vila MM,  Jakesz R,  Demol J,  Dewar J,  Santoro A,  Lluch A,  Olsen S,  Gelber RD,  Di Leo A,  Piccart-Gebhart M
Breast Cancer Res Treat 2010 Jan;119(1):145-53
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 19731015
PMC ID: not available

National Institutes of Health State-of-the-Science Conference on the Management and Diagnosis of Ductal Carcinoma in Situ: a call to action.

McCaskill-Stevens W
J Natl Cancer Inst Monogr 2010;2010(41):111-2
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 20956812
PMC ID: PMC5161069

Carcinoma in situ outcomes in National Surgical Adjuvant Breast and Bowel Project Breast Cancer Chemoprevention Trials.

Vogel VG,  Costantino JP,  Wickerham DL,  McCaskill-Stevens W,  Clarfeld RB,  Grant MD,  Wolmark N
J Natl Cancer Inst Monogr 2010;2010(41):181-6
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program
PubMed ID: 20956826
PMC ID: PMC5161067
Clinical Trials: Breast Cancer Prevention Trial (BCPT) ;  Study of Tamoxifen and Raloxifene (STAR)

Breast cancer risk assessments comparing Gail and CARE models in African-American women.

Adams-Campbell LL,  Makambi KH,  Frederick WA,  Gaskins M,  Dewitty RL,  McCaskill-Stevens W
Breast J 2009 Sep-Oct;15 Suppl 1:S72-5
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 19775333
PMC ID: PMC3760176

Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA Trial.

Dowsett M,  Procter M,  McCaskill-Stevens W,  de Azambuja E,  Dafni U,  Rueschoff J,  Jordan B,  Dolci S,  Abramovitz M,  Stoss O,  Viale G,  Gelber RD,  Piccart-Gebhart M,  Leyland-Jones B
J Clin Oncol 2009 Jun 20;27(18):2962-9
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 19364966
PMC ID: PMC2701645

Learning from experience.

Trimble EL,  McCaskill-Stevens W,  Denicoff A,  Minig L,  Minasian LM
Oncologist 2009 May;14(5):476-7
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director
PubMed ID: 19417099
PMC ID: not available

Projecting individualized absolute invasive breast cancer risk in African American women.

Gail MH,  Costantino JP,  Pee D,  Bondy M,  Newman L,  Selvan M,  Anderson GL,  Malone KE,  Marchbanks PA,  McCaskill-Stevens W,  Norman SA,  Simon MS,  Spirtas R,  Ursin G,  Bernstein L
J Natl Cancer Inst 2007 Dec 5;99(23):1782-92
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program ;  Community Clinical Oncology Program
PubMed ID: 18042936
PMC ID: not available
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Challenges and recommendations for advancing the state-of-the-science of quality of life assessment in symptom management trials.

Buchanan DR,  O'Mara AM,  Kelaghan JW,  Sgambati M,  McCaskill-Stevens W,  Minasian L
Cancer 2007 Oct 1;110(7):1621-8
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 17868120
PMC ID: not available

Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.

Messina M,  McCaskill-Stevens W,  Lampe JW
J Natl Cancer Inst 2006 Sep 20;98(18):1275-84
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 16985246
PMC ID: not available

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Vogel VG,  Costantino JP,  Wickerham DL,  Cronin WM,  Cecchini RS,  Atkins JN,  Bevers TB,  Fehrenbacher L,  Pajon ER Jr,  Wade JL 3rd,  Robidoux A,  Margolese RG,  James J,  Lippman SM,  Runowicz CD,  Ganz PA,  Reis SE,  McCaskill-Stevens W,  Ford LG,  Jordan VC,  Wolmark N,  National Surgical Adjuvant Breast and Bowel Project (NSABP)
JAMA 2006 Jun 21;295(23):2727-41
Major Program(s) or Research Group(s): Community Oncology and Prevention TrialsNCI Community Oncology Research Program ;  Office of the Director ;  Community Clinical Oncology Program
PubMed ID: 16754727
PMC ID: not available
Clinical Trials: Study of Tamoxifen and Raloxifene (STAR)

Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience.

McCaskill-Stevens W,  McKinney MM,  Whitman CG,  Minasian LM
J Clin Oncol 2005 Aug 1;23(22):5247-54
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Community Clinical Oncology Program
PubMed ID: 16051967
PMC ID: not available

Barriers to racial/ethnic minority application and competition for NIH research funding.

Shavers VL,  Fagan P,  Lawrence D,  McCaskill-Stevens W,  McDonald P,  Browne D,  McLinden D,  Christian M,  Trimble E
J Natl Med Assoc 2005 Aug;97(8):1063-77
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 16173321
PMC ID: PMC2575989

Contralateral breast cancer and thromboembolic events in African American women treated with tamoxifen.

McCaskill-Stevens W,  Wilson J,  Bryant J,  Mamounas E,  Garvey L,  James J,  Cronin W,  Wickerham DL
J Natl Cancer Inst 2004 Dec 1;96(23):1762-9
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 15572758
PMC ID: not available

Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention.

Freedman AN,  Graubard BI,  Rao SR,  McCaskill-Stevens W,  Ballard-Barbash R,  Gail MH
J Natl Cancer Inst 2003 Apr 2;95(7):526-32
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 12671020
PMC ID: not available

Prevention and early detection clinical trials: opportunities for primary care providers and their patients.

Ford LG,  Minasian LM,  McCaskill-Stevens W,  Pisano ED,  Sullivan D,  Smith RA
CA Cancer J Clin 2003 Mar-Apr;53(2):82-101
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials ;  Office of the Director
PubMed ID: 12691266
PMC ID: not available

Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors.

Giuliano AR,  Mokuau N,  Hughes C,  Tortolero-Luna G,  Risendal B,  Ho RCS,  Prewitt TE,  McCaskill-Stevens WJ
Ann Epidemiol 2000 Nov;10(8 Suppl):S22-34
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 11189089
PMC ID: not available

Physician perspectives on increasing minorities in cancer clinical trials: an Eastern Cooperative Oncology Group (ECOG) Initiative.

Pinto HA,  McCaskill-Stevens W,  Wolfe P,  Marcus AC
Ann Epidemiol 2000 Nov;10(8 Suppl):S78-84
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 11189096
PMC ID: not available

Breast cancer prevention: the next steps.

Dunn BK,  McCaskill-Stevens W,  Ford LG
Eur J Cancer 2000 Sep;36 Suppl 4:S53-4
Major Program(s) or Research Group(s): Chemopreventive Agent DevelopmentCommunity Oncology and Prevention Trials ;  Office of the Director
PubMed ID: 11056319
PMC ID: not available

National Cancer Institute--supported cancer chemoprevention research: coming of age.

McCaskill-Stevens W,  Hawk ET,  Flynn PJ,  Lippman SM
J Clin Oncol 1999 Nov;17(11 Suppl):53-62
Major Program(s) or Research Group(s): Chemopreventive Agent Development
PubMed ID: 10630263
PMC ID: not available

Combination versus sequential doxorubicin and docetaxel as primary chemotherapy for breast cancer: A randomized pilot trial of the Hoosier Oncology Group.

Miller KD,  McCaskill-Stevens W,  Sisk J,  Loesch DM,  Monaco F,  Seshadri R,  Sledge GW Jr
J Clin Oncol 1999 Oct;17(10):3033-7
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 10506597
PMC ID: not available

Promoting cancer screening among the first-degree relatives of breast and colorectal cancer patients: the design of two randomized trials.

Marcus AC,  Ahnen D,  Cutter G,  Calonge N,  Russell S,  Sedlacek SM,  Wood M,  Manchester D,  Fox L,  McCaskill-Stevens W,  Fairclough D,  Hines S,  Wenzel L,  Osborn K
Prev Med 1999 Mar;28(3):229-42
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 10072740
PMC ID: not available

Recruiting minority cancer patients into cancer clinical trials: a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association.

McCaskill-Stevens W,  Pinto H,  Marcus AC,  Comis R,  Morgan R,  Plomer K,  Schoentgen S
J Clin Oncol 1999 Mar;17(3):1029-39
Major Program(s) or Research Group(s): Community Oncology and Prevention Trials
PubMed ID: 10071298
PMC ID: not available